X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DISHMAN PHARMA UNICHEM LAB/
DISHMAN PHARMA
 
P/E (TTM) x 32.8 25.1 130.8% View Chart
P/BV x 3.5 3.3 103.2% View Chart
Dividend Yield % 0.5 0.7 82.8%  

Financials

 UNICHEM LAB   DISHMAN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
DISHMAN PHARMA
Mar-16
UNICHEM LAB/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs334374 89.2%   
Low Rs174129 135.0%   
Sales per share (Unadj.) Rs146.9197.8 74.3%  
Earnings per share (Unadj.) Rs11.921.2 56.1%  
Cash flow per share (Unadj.) Rs16.234.7 46.6%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.8 99.1%  
Book value per share (Unadj.) Rs105.1179.9 58.4%  
Shares outstanding (eoy) m90.8480.69 112.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.3 135.9%   
Avg P/E ratio x21.411.9 180.0%  
P/CF ratio (eoy) x15.77.2 216.5%  
Price / Book Value ratio x2.41.4 172.7%  
Dividend payout %16.89.4 178.3%   
Avg Mkt Cap Rs m23,07320,306 113.6%   
No. of employees `0005.70.8 684.3%   
Total wages/salary Rs m2,5585,355 47.8%   
Avg. sales/employee Rs Th2,352.519,252.7 12.2%   
Avg. wages/employee Rs Th450.96,459.5 7.0%   
Avg. net profit/employee Rs Th190.42,064.1 9.2%   
INCOME DATA
Net Sales Rs m13,34615,961 83.6%  
Other income Rs m192265 72.3%   
Total revenues Rs m13,53816,226 83.4%   
Gross profit Rs m1,6394,103 39.9%  
Depreciation Rs m3901,091 35.8%   
Interest Rs m29944 3.0%   
Profit before tax Rs m1,4122,334 60.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-41 -336.4%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293624 46.9%   
Profit after tax Rs m1,0801,711 63.1%  
Gross profit margin %12.325.7 47.8%  
Effective tax rate %20.726.7 77.6%   
Net profit margin %8.110.7 75.5%  
BALANCE SHEET DATA
Current assets Rs m5,97911,018 54.3%   
Current liabilities Rs m2,4329,517 25.6%   
Net working cap to sales %26.69.4 282.7%  
Current ratio x2.51.2 212.4%  
Inventory Days Days63110 57.1%  
Debtors Days Days6035 173.3%  
Net fixed assets Rs m6,40316,304 39.3%   
Share capital Rs m182161 112.6%   
"Free" reserves Rs m9,29312,907 72.0%   
Net worth Rs m9,54814,516 65.8%   
Long term debt Rs m2304,189 5.5%   
Total assets Rs m12,84329,805 43.1%  
Interest coverage x50.03.5 1,441.4%   
Debt to equity ratio x00.3 8.4%  
Sales to assets ratio x1.00.5 194.1%   
Return on assets %8.68.9 96.9%  
Return on equity %11.311.8 96.0%  
Return on capital %14.317.5 81.8%  
Exports to sales %29.224.8 117.9%   
Imports to sales %6.33.7 169.8%   
Exports (fob) Rs m3,9003,956 98.6%   
Imports (cif) Rs m847596 142.0%   
Fx inflow Rs m4,3564,952 88.0%   
Fx outflow Rs m1,162697 166.8%   
Net fx Rs m3,1944,255 75.1%   
CASH FLOW
From Operations Rs m1,1192,786 40.2%  
From Investments Rs m-853-1,529 55.8%  
From Financial Activity Rs m-334-941 35.5%  
Net Cashflow Rs m-68316 -21.6%  

Share Holding

Indian Promoters % 50.1 61.4 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.7 408.1%  
FIIs % 3.0 12.7 23.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 22.1 143.4%  
Shareholders   20,176 46,261 43.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUVEN LIFE  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SHASUN PHARMA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - SUN PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS